Biosimilar-Related IPR Petitions include IPR petitions relating to biosimilar/follow-on products. IPR petitions relating to disputes between reference product sponsors, or non-practicing entities/universities and reference product sponsors are not included. IPR petitions relating to manufacturing patents that may be relevant to multiple products (for example, U.S. Patent No. 6,331,415 (a “Cabilly” patent)) also are not included. Outcomes listed are the initial decisions by the PTAB and do not include decisions on appeal.
BiologicsHQ and materials published on BiologicsHQ are published for informational purposes only. Neither the information nor any opinion expressed on BiologicsHQ constitute legal advice, create an attorney-client relationship, or constitute a solicitation for business.